Although various studies have deepened our understanding of HCC carcinogenesis, HCC surveillance mainly relies on abdominal ultrasonography and blood alpha-fetoprotein (AFP) measurements in high-risk groups with hepatitis B, hepatitis C, and liver cirrhosis (LC) [3–5]. This evidence concerns the gene AFP and hepatitis B virus infection.